HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ke-Neng Chen Selected Research
Ke-Neng Chen Research Topics
Disease
18
Neoplasms (Cancer)
11/2021 - 12/2002
16
Esophageal Squamous Cell Carcinoma
02/2024 - 02/2005
13
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2023 - 01/2017
5
Esophageal Neoplasms (Esophageal Cancer)
10/2022 - 05/2014
5
Lung Neoplasms (Lung Cancer)
01/2022 - 01/2017
4
Thymoma (Thymic Carcinoma)
07/2016 - 07/2016
3
Neoplasm Metastasis (Metastasis)
11/2021 - 08/2016
3
Thymus Neoplasms (Thymus Neoplasm)
07/2016 - 07/2016
2
Myasthenia Gravis
07/2016 - 07/2016
1
Pathologic Complete Response
01/2024
1
Chylothorax
05/2023
1
Disease Progression
01/2022
1
Acute Lung Injury
01/2022
1
Plasmacytoma
11/2021
1
Lymphatic Metastasis
03/2020
1
Melanoma (Melanoma, Malignant)
03/2020
1
Pulmonary Atelectasis
01/2019
1
Neutropenia
01/2018
1
Vomiting
01/2018
1
Interstitial Lung Diseases (Interstitial Lung Disease)
01/2018
1
Carcinogenesis
05/2014
1
Esophageal Diseases
05/2014
1
Infections
07/2005
1
Carcinoma (Carcinomatosis)
12/2002
1
Breast Neoplasms (Breast Cancer)
12/2002
Drug/Important Bio-Agent (IBA)
6
Cisplatin (Platino)
FDA Link
Generic
01/2023 - 01/2018
5
Gefitinib (Iressa)
FDA Link
11/2021 - 01/2018
3
Biomarkers (Surrogate Marker)
IBA
10/2022 - 01/2016
3
Vinorelbine (Navelbine)
FDA Link
Generic
01/2021 - 01/2018
3
ErbB Receptors (EGF Receptor)
IBA
01/2021 - 01/2019
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2023 - 01/2019
2
Gemcitabine
FDA Link
01/2023 - 01/2019
1
Immune Checkpoint Inhibitors
IBA
08/2023
1
pembrolizumab
IBA
08/2023
1
Nivolumab
IBA
01/2022
1
Complement System Proteins (Complement)
IBA
12/2020
1
phosphatidyl-N-monomethylaminoethanol
IBA
03/2020
1
Platinum
IBA
11/2019
1
Cullin Proteins (Cullins)
IBA
01/2019
1
Kelch-Like ECH-Associated Protein 1
IBA
01/2019
1
Tyrosine Kinase Inhibitors
IBA
01/2019
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2019
1
berzosertib
IBA
01/2018
1
histone H3 trimethyl Lys4
IBA
01/2018
1
Cadherins (E-Cadherin)
IBA
02/2017
1
Circulating Tumor DNA
IBA
01/2017
1
Annexin A2 (Annexin II)
IBA
05/2014
1
superoxide dismutase 2
IBA
05/2014
1
Endopeptidases
IBA
08/2005
1
Zinc
IBA
08/2005
1
Matrix Metalloproteinases (MMPs)
IBA
08/2005
1
Digoxin (Digitek)
FDA Link
Generic
07/2005
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
02/2005
1
homeobox protein HOXA9
IBA
02/2005
1
Codon (Codons)
IBA
12/2002
Therapy/Procedure
14
Drug Therapy (Chemotherapy)
01/2023 - 12/2015
11
Therapeutics
11/2021 - 07/2016
8
Neoadjuvant Therapy
02/2024 - 01/2016
5
Esophagectomy
05/2023 - 05/2014
4
Adjuvant Chemotherapy
01/2022 - 01/2018
3
Immunotherapy
09/2022 - 06/2018
3
Radiotherapy
03/2022 - 07/2016
2
Thymectomy
07/2016 - 07/2016
1
Ligation
05/2023
1
Adjuvant Radiotherapy
11/2021
1
Lymph Node Excision (Lymph Node Dissection)
07/2020
1
One-Lung Ventilation
01/2019
1
Induction Chemotherapy
01/2019
1
Precision Medicine
01/2017
1
Radiofrequency Ablation
08/2016